HCPLive Network

Antipsychotics Induce Insulin Resistance Without Weight Gain

THURSDAY, July 18 (HealthDay News) -- Atypical antipsychotic drugs induce insulin resistance even in the absence of weight gain and mechanisms regulating eating behavior, according to a study published online July 8 in Diabetes.

To examine whether atypical antipsychotic drugs have detrimental metabolic effects independent of weight gain or psychiatric disease, Karen L. Teff, PhD, from the Monell Chemical Senses Center in Philadelphia, and colleagues treated healthy people as inpatients in a controlled setting with olanzapine, aripiprazole, or placebo for nine days (10 people per group) while maintaining activity levels.

The researchers found that, compared with placebo, olanzapine (which has been strongly associated with weight gain) treatment was associated with significant increases in postprandial insulin, glucagon-like peptide 1, and glucagon, as well as insulin resistance. In contrast, aripiprazole (which has been considered metabolically sparing) had no effect on postprandial hormones but also induced insulin resistance. The changes occurred without weight gain, increase in food intake and hunger, or psychiatric disease.

"Our findings suggest that interventions inhibiting weight gain in atypical antipsychotic-treated patients may be only partially effective in preventing metabolic disease since the drugs are exerting direct effects on tissue function," Teff and colleagues conclude.

Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
Variants of a gene are associated with overweight and obesity in psychiatric patients taking drugs that induce weight gain, as well in the general population.
Results from genetic testing for weight gain-related genes may offer psychological benefits beyond their limited clinical utility.
A single, afternoon session of moderate exercise improves insulin sensitivity the next day in obese adults.
Following the American Medical Association's formal recognition of obesity as a disease, Boston University researchers attempted to identify better ways to determine health status in obese patients.
To decrease the rates of obesity and type 2 diabetes mellitus (T2DM), a recent study has recommended a ban on sugar-sweetened drinks among food stamp recipients and endorsed an incentive program to encourage healthier eating habits.
Previous studies may have underestimated the impact of the obesity epidemic on US mortality, according to a study published online Aug. 15 in the American Journal of Public Health.
A team of German researchers has identified differences in metabolic health patterns across an obese population.
More Reading